Standalone live-attenuated mumps vaccine (now administered as part of MMR)
This page catalogs 1 standalone mumps vaccine product. The Jeryl Lynn strain, isolated by Maurice Hilleman from his daughter in 1963, became the basis for the first licensed mumps vaccine in 1967. Standalone mumps vaccination was largely replaced by the combination MMR (measles-mumps-rubella) vaccine. Current mumps vaccination in the United States is administered exclusively through combination products such as M-M-R II and ProQuad.
Last updated: April 2026.
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Mumpsvax | Mumps virus vaccine, live (Jeryl Lynn) | Merck | Live-attenuated viral | FDA Licensed, 1967; Discontinued | Standalone mumps; replaced by MMR |
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.